South African Press Association - October 16, 2006
"About 178 635 people had been initiated on antiretroviral therapy in the 262 accredited facilities in the country by June this year," said spokesperson Charity Bengu.
She said 31 255 patients were on the waiting list to receive the treatment during the same period.
"This number of patients on the waiting list is significantly lower than the figure of between 500 000 and 800 000 that was released by the Treatment Action Campaign (TAC).
"It arrived at the figure by assuming that between 10% to 15% of people currently estimated to be living with HIV/Aids have progressed to a stage of 200 CD4 or below and therefore may need ARVs," said Bengu.
She said the TAC's model did not necessarily take into consideration the impact of healthy lifestyle interventions in delaying progression from HIV infection to development of Aids-defining conditions.
"Antiretroviral drugs can prolong life at the latter stage, but healthy lifestyle interventions are also important."
Patients on the waiting list are those who had undergone voluntary counselling and testing and had been assessed for CD4 count, viral load and clinically at stage three or four of the disease, she said.
Limited capacity, particularly with regard to staffing and space in accredited facilities, required that some of the patients remained on the waiting list for a certain period before they underwent clinical evaluation and treatment was initiated.
The limited human-resource capacity at a pharmacy level remained one of the major challenges the department was trying to address.
"Pharmacists need to have a one-on-one session with every patient to reinforce the messages on the importance of compliance and adherence to the specific times at which the medication has to be taken," said Bengu.
Adherence was critical because if patients missed their specified time for taking medicine for more than an hour, they had risk of developing resistance.
Bengu said the department was determined to ensure that "everyone progressively realises the right of access to prevention, care and treatment services".
061016
SA061007
Copyright © 2006 - South African Press Association. Reproduction of this article (other than one copy for personal reference) must be cleared through the South African Press Association, Cotswold House, Greenacres Office Park, Cnr. Victory & Rustenburg Roads, VICTORY PARK, PO BOX 7766, JOHANNESBURG, 2000; Fax No: +27 11 782-1587/8, Tel No: +27 11 782-1600.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.
Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .